SPX3,744.52-38.76 -1.02%
DIA299.23-3.56 -1.18%
IXIC11,073.31-75.33 -0.68%

Timber Pharmaceuticals Receives Positive European Opinion on Orphan Designation for Skin Condition Treatment; Shares Rise

Timber Pharmaceuticals Receives Positive European Opinion on Orphan Designation for Skin Condition Treatment; Shares Rise

MT Newswires · 09/14/2022 06:30

Please log in to view news